Status:
COMPLETED
A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Queen Mary Hospital, Hong Kong
Kowloon Hospital, Hong Kong
Conditions:
Major Depressive Disorder
Depression
Eligibility:
All Genders
22-65 years
Phase:
NA
Brief Summary
This is a randomized, assessor-blind, placebo controlled study in major depressive disorder (MDD) patients. Subjects receiving antidepressant drug (FLX) would be assigned to receive either 18 sham / a...
Detailed Description
Although the development of various classes of antidepressant drugs, represented by selective serotonin reuptake inhibitors (SSRI), has considerably improved the prognosis and the tolerability in the ...
Eligibility Criteria
Inclusion
- with righthandedness;
- have first-episode MDD diagnosed as the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV); and
- HAMD-17 score is ≥ 20; and
- never had any psychoactive medications.
Exclusion
- unstable medical conditions;
- have suicidal ideas or attempts or aggressive behavior;
- previously experienced manic, hypomanic, or mixed episode;
- immediate family members have bipolar or psychotic disorders;
- treatment with investigational drugs in past 6 months;
- alcoholism or drug abuse in past 1 year; or
- have needle phobia.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01479920
Start Date
June 1 2012
End Date
May 1 2015
Last Update
December 7 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Traditional Chinese Medicine, Southern Medical University
Guangzhou, China
2
Department of Psychiatry, Queen Mary Hospital
Hong Kong, China
3
Department of Psychiatry, Kowloon Hospital
Kowloon, China
4
Department of Diagnostic Radiology, The University of Hong Kong
Hong Kong, Hong Kong